Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 23251-23300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06008977
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
NARecruiting
20 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06368830
Oral and Swallowing Function in Older Adults
N/ARecruiting
200 participants
Started: Jun 3, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06479135
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
PHASE3Recruiting
600 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2028
5 conditions1 sponsor215 locations
NCT06275555
Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation
NARecruiting
154 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05881304
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
NARecruiting
40 participants
Started: Jun 3, 2024 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT06447740
Fractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery Stenosis
NARecruiting
200 participants
Started: Jun 3, 2024 · Completed: Apr 3, 2027
2 conditions1 sponsor1 location
NCT06583876
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study
NARecruiting
15 participants
Started: Jun 3, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor4 locations
NCT06378866
Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial
PHASE2Recruiting
220 participants
Started: Jun 3, 2024 · Completed: May 31, 2029
4 conditions2 sponsors2 locations
NCT06278779
Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression
PHASE4Recruiting
162 participants
Started: Jun 3, 2024 · Completed: Apr 30, 2027
1 condition2 sponsors6 locations
NCT05523999
Recognition of a Cardiac Arrest Within the EMS
N/ARecruiting
50 participants
Started: Jun 3, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06492746
Personal BP - CAI Study
NARecruiting
120 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06251635
Effects of Antipsychotics on Brain Insulin Action in Females
NARecruiting
15 participants
Started: Jun 3, 2024 · Completed: Mar 1, 2026
4 conditions1 sponsor1 location
NCT06462443
A Prospective Study of RISE for Physicians
NARecruiting
36 participants
Started: Jun 3, 2024 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06440395
Small Steps for Big Changes - Healthy Cities Implementation Science
N/ARecruiting
4,400 participants
Started: Jun 3, 2024 · Completed: Sep 30, 2029
1 condition7 sponsors12 locations
NCT06640166
Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
PHASE2Recruiting
25 participants
Started: Jun 3, 2024 · Completed: Jun 30, 2026
10 conditions2 sponsors3 locations
NCT06122233
A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
NARecruiting
400 participants
Started: Jun 3, 2024 · Completed: Aug 31, 2027
2 conditions4 sponsors4 locations
NCT06008431
Non-invasive Brain Stimulation to Improve Unsteady Gait in Older Adults (StimGait)
NARecruiting
30 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06282406
Pupil-Indexed Noninvasive Neuromodulation
NARecruiting
110 participants
Started: Jun 3, 2024 · Completed: Aug 5, 2028
1 condition1 sponsor1 location
NCT06383091
Impact of Manual Therapy on Laryngeal Function Following Total Thyroidectomy
NARecruiting
20 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06501599
AI-based System for Assessing Suspected Viral Pneumonia Related Lung Changes
N/ARecruiting
563 participants
Started: Jun 3, 2024 · Completed: Dec 3, 2025
2 conditions2 sponsors1 location
NCT06364176
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
PHASE2Recruiting
42 participants
Started: Jun 3, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT06466356
Psychoeducational Course for Suicide Prevention
NARecruiting
80 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2031
6 conditions3 sponsors2 locations
NCT05670132
Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB)
NARecruiting
290 participants
Started: Jun 3, 2024 · Completed: Jun 3, 2027
1 condition1 sponsor5 locations
NCT06428032
Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy
NARecruiting
48 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06468527
Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF
PHASE2Recruiting
52 participants
Started: Jun 3, 2024 · Completed: Jun 1, 2025
1 condition2 sponsors16 locations
NCT06437184
Increased Tuberculosis Case Detection - DiOpTB
NARecruiting
1,584 participants
Started: Jun 3, 2024 · Completed: Mar 31, 2026
1 condition3 sponsors2 locations
NCT06351761
WIBOFA - Validation of SCT02 With ECG-App for Detection of AF
NARecruiting
371 participants
Started: Jun 3, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor4 locations
NCT06290999
Study of Multifrequential Impedancemetry in Pulsatile Tinnitus
N/ARecruiting
50 participants
Started: Jun 3, 2024 · Completed: Mar 15, 2026
1 condition1 sponsor1 location
NCT06607562
Effectiveness and Safety of Probiotics in Protecting Liver Function
NARecruiting
80 participants
Started: Jun 3, 2024 · Completed: Apr 15, 2025
1 condition1 sponsor1 location
NCT06523127
Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues
N/ARecruiting
14 participants
Started: Jun 3, 2024 · Completed: Sep 30, 2024
3 conditions1 sponsor1 location
NCT05627219
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
N/ARecruiting
30 participants
Started: Jun 3, 2024 · Completed: Apr 29, 2026
4 conditions1 sponsor1 location
NCT06448208
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
N/ARecruiting
50 participants
Started: Jun 3, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06054295
Somatic Mosaicism in Twins Discordant for Childhood Cancer
N/ARecruiting
50 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06604364
Virtual Reality for Reducing Anxiety in Pediatric Orthopedic Surgery
NARecruiting
50 participants
Started: Jun 3, 2024 · Completed: Jun 3, 2026
1 condition1 sponsor1 location
NCT05880108
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
NARecruiting
150 participants
Started: Jun 3, 2024 · Completed: Sep 30, 2028
2 conditions3 sponsors2 locations
NCT06305962
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
EARLY_PHASE1Recruiting
23 participants
Started: Jun 3, 2024 · Completed: Oct 31, 2025
7 conditions1 sponsor6 locations
NCT06362122
Anatomo-clinico-biological Profiles in Severe Nasal Polyps
NARecruiting
200 participants
Started: Jun 3, 2024 · Completed: Oct 3, 2026
1 condition1 sponsor1 location
NCT06177821
Rezum for 30-80ml Patients With Moderate-severe LUTS to Study Surgical Principles for Median Lobe Enlargement
NARecruiting
44 participants
Started: Jun 3, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06447402
A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis
PHASE3Recruiting
196 participants
Started: Jun 3, 2024 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT06507306
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
PHASE1Recruiting
100 participants
Started: Jun 3, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor34 locations
NCT06477887
Post Extraction Changes Following Ridge Preservation Using Allogenis Dentin Vs Autogenous Partially Demineralized Dentin
NARecruiting
32 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT07198568
Relationship Between Swallowing Dynamics and Suprahyoid Muscle Activity in Sarcopenic Dysphagia
N/ARecruiting
50 participants
Started: Jun 3, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT06363877
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
PHASE3Recruiting
1,100 participants
Started: Jun 3, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06476886
Intensive Crisis Intervention
NARecruiting
213 participants
Started: Jun 3, 2024 · Completed: Jul 31, 2026
5 conditions3 sponsors1 location
NCT06511518
Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment
NARecruiting
64 participants
Started: Jun 3, 2024 · Completed: Feb 1, 2026
2 conditions2 sponsors1 location
NCT05947266
Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes
NARecruiting
66 participants
Started: Jun 3, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06384664
Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy
NARecruiting
80 participants
Started: Jun 3, 2024 · Completed: Apr 30, 2028
2 conditions2 sponsors1 location
NCT06448936
Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical Outcomes.
N/ARecruiting
750 participants
Started: Jun 3, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06416670
Skilled Nursing Facility Care At Home
NARecruiting
300 participants
Started: Jun 3, 2024 · Completed: Jan 31, 2026
2 conditions3 sponsors5 locations
NCT06540352
A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form
PHASE2Recruiting
200 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location